2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Andrew B Lassman, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas Cytoreductive surgery, Perifosine, Temsirolimus - Brain Tumor, Recurrent, Glioblastoma | Phase 1 | Completed | Andrew B Lassman, MD | 10 | 2014-12-08 | 2023-05-25 |
| EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas erlotinib, Cytoreductive Surgery - Brain Cancer | Phase 1 | Completed | Andrew B Lassman, MD | 22 | 2011-01-07 | 2023-05-25 |
Brain Neoplasms (2) · Glioblastoma (2) · Glioma (2) · Astrocytoma (1) · Gliosarcoma (1) · Oligodendroglioma (1)
Cytoreduction Surgical Procedures (2) · Erlotinib Hydrochloride (1) · perifosine (1) · temsirolimus (1)
United States (2)
Andrew B. Lassman, MD (1) · Andrew Lassman, MD (1)